610.41
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché META Giù?
Forum
Previsione
Precedente Chiudi:
$608.75
Aprire:
$607.935
Volume 24 ore:
16.13M
Relative Volume:
1.01
Capitalizzazione di mercato:
$1.55T
Reddito:
$214.96B
Utile/perdita netta:
$70.59B
Rapporto P/E:
22.19
EPS:
27.5066
Flusso di cassa netto:
$48.25B
1 W Prestazione:
-10.05%
1M Prestazione:
+6.26%
6M Prestazione:
-2.70%
1 anno Prestazione:
+2.24%
Meta Platforms Inc Stock (META) Company Profile
Nome
Meta Platforms Inc
Settore
Industria
Telefono
650-543-4800
Indirizzo
1 META WAY, MENLO PARK
Compare META vs GOOGL, GOOG, SPOT, DASH
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
META
Meta Platforms Inc
|
610.41 | 1.55T | 214.96B | 70.59B | 48.25B | 27.51 |
|
GOOGL
Alphabet Inc
|
383.25 | 4.64T | 423.17B | 160.21B | 64.43B | 12.78 |
|
GOOG
Alphabet Inc
|
379.64 | 4.60T | 423.17B | 160.21B | 64.43B | 12.78 |
|
SPOT
Spotify Technology Sa
|
438.26 | 90.12B | 20.32B | 3.16B | 3.82B | 12.55 |
|
DASH
Doordash Inc
|
172.57 | 75.20B | 13.72B | 932.00M | 1.83B | 2.1265 |
Meta Platforms Inc Stock (META) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-30 | Downgrade | JP Morgan | Overweight → Neutral |
| 2026-04-10 | Reiterato | Wolfe Research | Outperform |
| 2026-04-09 | Reiterato | Rosenblatt | Buy |
| 2026-04-02 | Downgrade | Erste Group | Buy → Hold |
| 2026-03-30 | Reiterato | Morgan Stanley | Overweight |
| 2026-03-05 | Downgrade | Arete | Buy → Neutral |
| 2026-03-05 | Aggiornamento | Erste Group | Hold → Buy |
| 2026-02-23 | Reiterato | Wells Fargo | Overweight |
| 2026-01-29 | Reiterato | Canaccord Genuity | Buy |
| 2026-01-29 | Reiterato | Cantor Fitzgerald | Overweight |
| 2026-01-29 | Reiterato | Deutsche Bank | Buy |
| 2026-01-29 | Reiterato | Evercore ISI | Outperform |
| 2026-01-29 | Reiterato | Guggenheim | Buy |
| 2026-01-29 | Reiterato | JP Morgan | Overweight |
| 2026-01-29 | Reiterato | Jefferies | Buy |
| 2026-01-29 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2026-01-29 | Reiterato | Mizuho | Outperform |
| 2026-01-29 | Reiterato | Monness Crespi & Hardt | Buy |
| 2026-01-29 | Reiterato | Morgan Stanley | Overweight |
| 2026-01-29 | Reiterato | Piper Sandler | Overweight |
| 2026-01-29 | Reiterato | Pivotal Research Group | Buy |
| 2026-01-29 | Reiterato | Robert W. Baird | Outperform |
| 2026-01-29 | Reiterato | Roth Capital | Buy |
| 2026-01-29 | Reiterato | Stifel | Buy |
| 2026-01-29 | Reiterato | UBS | Buy |
| 2026-01-29 | Reiterato | Wedbush | Outperform |
| 2026-01-29 | Reiterato | Wells Fargo | Overweight |
| 2026-01-29 | Reiterato | Wolfe Research | Outperform |
| 2026-01-26 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2026-01-26 | Reiterato | Raymond James | Strong Buy |
| 2026-01-26 | Aggiornamento | Rothschild & Co Redburn | Neutral → Buy |
| 2026-01-23 | Reiterato | Stifel | Buy |
| 2026-01-13 | Reiterato | TD Cowen | Buy |
| 2026-01-12 | Reiterato | Wells Fargo | Overweight |
| 2026-01-08 | Reiterato | Cantor Fitzgerald | Overweight |
| 2026-01-08 | Reiterato | Guggenheim | Buy |
| 2025-12-04 | Aggiornamento | Arete | Neutral → Buy |
| 2025-11-24 | Iniziato | BNP Paribas Exane | Outperform |
| 2025-11-10 | Downgrade | Erste Group | Buy → Hold |
| 2025-10-30 | Reiterato | Barclays | Overweight |
| 2025-10-30 | Reiterato | Bernstein | Outperform |
| 2025-10-30 | Reiterato | BofA Securities | Buy |
| 2025-10-30 | Reiterato | Citigroup | Buy |
| 2025-10-30 | Reiterato | JP Morgan | Overweight |
| 2025-10-30 | Reiterato | Jefferies | Buy |
| 2025-10-30 | Reiterato | Mizuho | Outperform |
| 2025-10-30 | Reiterato | Monness Crespi & Hardt | Buy |
| 2025-10-30 | Downgrade | Oppenheimer | Outperform → Perform |
| 2025-10-30 | Reiterato | Piper Sandler | Overweight |
| 2025-10-30 | Reiterato | Stifel | Buy |
| 2025-10-30 | Downgrade | The Benchmark Company | Buy → Hold |
| 2025-10-20 | Reiterato | Oppenheimer | Outperform |
| 2025-10-07 | Reiterato | Wells Fargo | Overweight |
| 2025-09-30 | Iniziato | Mizuho | Outperform |
| 2025-07-31 | Reiterato | BMO Capital Markets | Market Perform |
| 2025-07-31 | Reiterato | Bernstein | Outperform |
| 2025-07-31 | Reiterato | BofA Securities | Buy |
| 2025-07-31 | Reiterato | Citigroup | Buy |
| 2025-07-31 | Reiterato | Citizens JMP | Mkt Outperform |
| 2025-07-31 | Reiterato | JP Morgan | Overweight |
| 2025-07-31 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2025-07-31 | Reiterato | Monness Crespi & Hardt | Buy |
| 2025-07-31 | Reiterato | Morgan Stanley | Overweight |
| 2025-07-31 | Reiterato | Oppenheimer | Outperform |
| 2025-07-31 | Reiterato | Pivotal Research Group | Buy |
| 2025-07-31 | Reiterato | TD Cowen | Buy |
| 2025-07-31 | Reiterato | UBS | Buy |
| 2025-07-31 | Reiterato | Wedbush | Outperform |
| 2025-07-31 | Reiterato | Wells Fargo | Overweight |
| 2025-07-28 | Reiterato | Guggenheim | Buy |
| 2025-07-16 | Reiterato | Canaccord Genuity | Buy |
| 2025-07-03 | Aggiornamento | Needham | Underperform → Hold |
| 2025-06-26 | Reiterato | UBS | Buy |
| 2025-06-24 | Reiterato | Citigroup | Buy |
| 2025-05-01 | Reiterato | BofA Securities | Buy |
| 2025-05-01 | Reiterato | Citigroup | Buy |
| 2025-05-01 | Reiterato | Evercore ISI | Outperform |
| 2025-05-01 | Reiterato | Goldman | Buy |
| 2025-05-01 | Reiterato | Guggenheim | Buy |
| 2025-05-01 | Reiterato | JP Morgan | Overweight |
| 2025-05-01 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2025-05-01 | Reiterato | MoffettNathanson | Buy |
| 2025-05-01 | Reiterato | Monness Crespi & Hardt | Buy |
| 2025-05-01 | Reiterato | Morgan Stanley | Overweight |
| 2025-05-01 | Reiterato | Oppenheimer | Outperform |
| 2025-05-01 | Reiterato | Piper Sandler | Overweight |
| 2025-05-01 | Reiterato | Pivotal Research Group | Buy |
| 2025-05-01 | Reiterato | Raymond James | Strong Buy |
| 2025-05-01 | Reiterato | Rosenblatt | Buy |
| 2025-05-01 | Reiterato | Roth Capital | Buy |
| 2025-05-01 | Reiterato | Stifel | Buy |
| 2025-05-01 | Reiterato | Truist | Buy |
| 2025-05-01 | Reiterato | UBS | Buy |
| 2025-05-01 | Reiterato | Wedbush | Outperform |
| 2025-04-14 | Reiterato | Citigroup | Buy |
| 2025-04-10 | Reiterato | Piper Sandler | Overweight |
| 2025-01-30 | Aggiornamento | The Benchmark Company | Hold → Buy |
| 2025-01-23 | Reiterato | BofA Securities | Buy |
| 2025-01-22 | Reiterato | Cantor Fitzgerald | Overweight |
| 2025-01-06 | Reiterato | Jefferies | Buy |
| 2025-01-03 | Reiterato | Wolfe Research | Outperform |
| 2024-10-31 | Reiterato | Monness Crespi & Hardt | Buy |
| 2024-10-31 | Reiterato | Pivotal Research Group | Buy |
| 2024-10-11 | Iniziato | Scotiabank | Sector Perform |
| 2024-10-09 | Reiterato | Cantor Fitzgerald | Overweight |
| 2024-10-01 | Iniziato | Pivotal Research Group | Buy |
| 2024-09-30 | Reiterato | Monness Crespi & Hardt | Buy |
| 2024-09-10 | Iniziato | DA Davidson | Buy |
| 2024-09-05 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-08-01 | Reiterato | BofA Securities | Buy |
| 2024-07-19 | Reiterato | Oppenheimer | Outperform |
| 2024-07-16 | Iniziato | Wolfe Research | Outperform |
| 2024-07-10 | Reiterato | TD Cowen | Buy |
| 2024-07-08 | Reiterato | Wells Fargo | Overweight |
| 2024-07-01 | Reiterato | Raymond James | Strong Buy |
| 2024-06-12 | Reiterato | BMO Capital Markets | Market Perform |
| 2024-05-02 | Iniziato | Exane BNP Paribas | Underperform |
| 2024-04-25 | Reiterato | Oppenheimer | Outperform |
| 2024-04-15 | Reiterato | Citigroup | Buy |
| 2024-04-11 | Reiterato | Piper Sandler | Overweight |
| 2024-04-08 | Reiterato | Oppenheimer | Outperform |
| 2024-04-04 | Reiterato | Jefferies | Buy |
| 2024-02-02 | Reiterato | Guggenheim | Buy |
| 2024-02-02 | Reiterato | JMP Securities | Mkt Outperform |
| 2024-02-02 | Reiterato | JP Morgan | Overweight |
| 2024-02-02 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2024-02-02 | Reiterato | Mizuho | Buy |
| 2024-02-02 | Reiterato | Monness Crespi & Hardt | Buy |
| 2024-02-02 | Reiterato | Morgan Stanley | Overweight |
| 2024-02-02 | Reiterato | Oppenheimer | Outperform |
| 2024-02-02 | Reiterato | Piper Sandler | Overweight |
| 2024-02-02 | Reiterato | ROTH MKM | Buy |
| 2024-02-02 | Reiterato | Raymond James | Strong Buy |
| 2024-02-02 | Reiterato | Robert W. Baird | Outperform |
| 2024-02-02 | Reiterato | Seaport Research Partners | Buy |
| 2024-02-02 | Reiterato | Stifel | Buy |
| 2024-02-02 | Reiterato | Susquehanna | Positive |
| 2024-02-02 | Reiterato | TD Cowen | Outperform |
| 2024-02-02 | Reiterato | UBS | Buy |
| 2024-02-02 | Reiterato | Wedbush | Outperform |
| 2024-02-02 | Reiterato | Wells Fargo | Overweight |
| 2024-02-02 | Reiterato | Wolfe Research | Outperform |
| 2024-01-23 | Reiterato | Citigroup | Buy |
| 2024-01-17 | Reiterato | Piper Sandler | Overweight |
| 2024-01-17 | Reiterato | Wells Fargo | Overweight |
| 2024-01-09 | Iniziato | BMO Capital Markets | Market Perform |
| 2023-12-20 | Ripresa | Raymond James | Strong Buy |
| 2023-10-24 | Iniziato | Seaport Research Partners | Buy |
| 2023-08-22 | Iniziato | Wedbush | Outperform |
| 2023-08-01 | Reiterato | Argus | Buy |
| 2023-07-28 | Aggiornamento | China Renaissance | Hold → Buy |
| 2023-07-27 | Aggiornamento | HSBC Securities | Reduce → Hold |
| 2023-07-27 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-07-25 | Reiterato | Mizuho | Buy |
| 2023-07-25 | Aggiornamento | New Street | Neutral → Buy |
| 2023-07-19 | Reiterato | Jefferies | Buy |
| 2023-07-19 | Reiterato | Truist | Buy |
| 2023-07-17 | Reiterato | Credit Suisse | Outperform |
| 2023-07-17 | Reiterato | Goldman | Buy |
| 2023-07-17 | Reiterato | JMP Securities | Mkt Outperform |
| 2023-07-13 | Aggiornamento | TD Cowen | Market Perform → Outperform |
| 2023-07-12 | Reiterato | Deutsche Bank | Buy |
| 2023-06-08 | Iniziato | Wells Fargo | Equal Weight |
| 2023-05-15 | Aggiornamento | Loop Capital | Hold → Buy |
| 2023-04-27 | Reiterato | Credit Suisse | Outperform |
| 2023-04-27 | Reiterato | Deutsche Bank | Buy |
| 2023-04-27 | Reiterato | Evercore ISI | Outperform |
| 2023-04-27 | Reiterato | Goldman | Buy |
| 2023-04-27 | Reiterato | Guggenheim | Buy |
| 2023-04-27 | Reiterato | JMP Securities | Mkt Outperform |
| 2023-04-27 | Reiterato | JP Morgan | Overweight |
| 2023-04-27 | Reiterato | Mizuho | Buy |
| 2023-04-27 | Reiterato | Monness Crespi & Hardt | Buy |
| 2023-04-27 | Reiterato | Morgan Stanley | Overweight |
| 2023-04-27 | Reiterato | Oppenheimer | Outperform |
| 2023-04-27 | Reiterato | Piper Sandler | Overweight |
| 2023-04-27 | Reiterato | RBC Capital Mkts | Outperform |
| 2023-04-27 | Reiterato | Raymond James | Outperform |
| 2023-04-27 | Reiterato | Robert W. Baird | Outperform |
| 2023-04-27 | Reiterato | Rosenblatt | Buy |
| 2023-04-27 | Reiterato | Stifel | Buy |
| 2023-04-27 | Reiterato | TD Cowen | Market Perform |
| 2023-04-27 | Reiterato | Truist | Buy |
| 2023-04-27 | Reiterato | Wolfe Research | Outperform |
Mostra tutto
Meta Platforms Inc Borsa (META) Ultime notizie
Meta’s Cheap Stock Is an Investor Trap - WSJ
Kerusso Capital Management LLC Raises Stock Position in Meta Platforms, Inc. $META - MarketBeat
Meta CEO Mark Zuckerberg Just Hinted at the Next Big Thing in AI -- and These 3 Stocks Will Likely Profit the Most - Yahoo Finance
Diversified Enterprises LLC Raises Stock Holdings in Meta Platforms, Inc. $META - MarketBeat
Geneos Wealth Management Inc. Grows Stake in Meta Platforms, Inc. $META - MarketBeat
Meta Platforms, Inc. $META Shares Sold by Arizona State Retirement System - MarketBeat
Meta Drops Post-Earnings, Is It Time to Buy - Gotrade
AGP Franklin LLC Grows Stock Position in Meta Platforms, Inc. $META - MarketBeat
Meta Platforms, Inc. (META.US) Reportedly in Talks with M Stanley (MS.US), JPM (JPM.US) for USD13B Financing Plan for Texas Data Center - AASTOCKS.com
Korean court rules in favor of Meta in closely watched corporate tax dispute - KED Global
Zuckerberg accuses New Mexico of 'overreach' as Meta bench trial begins - Santa Fe New Mexican
CMBI Maintains Buy on Meta Platforms, Inc. (META.US), Raises Revenue Forecast - AASTOCKS.com
Big Tech AI Capex Frenzy: Meta, Alphabet Lead 2026 Spend - Gotrade
CoreWeave Meta Deal Deepens AI Hyperscaler Ties And Capacity Commitments - Yahoo Finance
META stock — $610.41 · +0.27% · $1.55T cap - Techi
New Mexico Attorney General Seeks Public Nuisance Ruling Against Meta Platforms, Inc. (META.US), Claims USD3.7B Compensation - AASTOCKS.com
New Mexico seeks child safety restrictions on Meta apps and algorithms in trial’s 2nd phase - AP News
New Mexico and Meta return to court for bench trial over public nuisance claims - KOAT
Meta's Revenue Growth Is Impressive, but Its AI Budget Is Getting Harder to Ignore - The Globe and Mail
Meta taps Morgan Stanley, JPMorgan for El Paso data center deal, Bloomberg News reports - Reuters
Meta's Revenue Growth Is Impressive, but Its AI Budget Is Getting Harder to Ignore - The Motley Fool
Meta Taps Morgan Stanley, JPMorgan for El Paso Data Center Deal - Bloomberg.com
Meta Platforms Completes $25 Billion Multi-Tranche Debt Offering - TipRanks
New Mexico seeks $3.7 billion, changes to Meta platforms in youth harm trial - Reuters
New Mexico AG criticizes Meta for threatening to shutdown platforms in state - KOMO
Meta's Revenue Growth Is Impressive, but This Remains a Big Problem - The Motley Fool
Meta pumps brakes on Menlo Park mixed-use megaproject amid 61% profit jump - The Real Deal
New Mexico seeks child safety restrictions on Meta apps and algorithms in trial's 2nd phase - NBC 7 San Diego
3 Overvalued Stocks to Take Profits In and 3 Undervalued Stocks to Buy Instead - Morningstar
DESIGN AND MANUFACTURING... - VitalLaw.com
Truist Reduces PT on Meta Platforms (META) Stock - Yahoo Finance
Meta Platforms vs Snap: Who’s Really Winning Digital Ads? - Yahoo Finance
New Mexico seeks changes to Meta platforms in youth harm trial - Maryland Daily Record
Meta Stock Buy or Sell in 2026: Why Wall Street Says Strong Buy Despite AI Spending Surge - International Business Times Australia
Jim Cramer Makes Big Change of Mind for Meta (META) - Yahoo Finance
Meta on trial in New Mexico in landmark case over alleged harm to children - NBC News
Meta Platforms: Why AI Is Still Driving Ads Growth And Value Creation (NASDAQ:META) - Seeking Alpha
International Markets and Meta Platforms (META): A Deep Dive for Investors - Yahoo Finance
Meta Platforms, Inc. (META) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
New Mexico judge to decide if Meta's actions are a public nuisance - KOAT
Meta AI Capex (Up 7%) Is a Bad Surprise -- Could This Be the Next Metaverse? - Yahoo Finance
JLens urges Meta shareholders to back content moderation report - Investing.com
West Michigan Advisors LLC Buys 1,202 Shares of Meta Platforms, Inc. $META - MarketBeat
WP Advisors LLC Grows Stake in Meta Platforms, Inc. $META - MarketBeat
JLens Urges Meta Shareholders to Vote FOR Proposal 8 at the Company’s Annual Meeting on May 27, 2026 - The Joplin Globe
Meta's public nuisance case in New Mexico has billion-dollar consequences - CNBC
Meta trial phase 2 starts Monday in Santa Fe - KOAT
State Healthcare Sites Are Sharing Personal Data with Big Tech - Bloomberg.com
How to Trade Meta After Q1 2026 Results - admiralmarkets.com
BofAS Raises Meta Platforms, Inc. (META.US) TP to USD835; 2Q Revenue Guidance In Line - AASTOCKS.com
Meta Platforms, Inc. $META Shares Sold by Milestone Asset Management LLC - MarketBeat
Meta Platforms Inc Azioni (META) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):